Prevention of postoperative VTE using Enoxaparin in laparoscopic gastrectomy and colectomy for malignancies.
- Conditions
- Gastric and colon cancer
- Registration Number
- JPRN-UMIN000011667
- Lead Sponsor
- Gastroenterological Surgery 1 Hokkaido Univ. Graduated School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 450
Not provided
1)Patients with heparin-induced thrombocytopenia or patients with a history of hypersensitivity of to heparin or related substances(HIT). 2)Patients with acute bacterial endocarditis 3)Patients with severe to moderate renal dysfunction(creatinine clearance below 50mL/min). 4)Patients with severe liver failure. 5)Low-weight patients (weight less than 40kg) 6)Women who may possibly be pregnant or are pregnant. 7)Patients receiving antiplatelet drugs (such as clopidogrel or aspirin) or anticoagulant drugs (warfarin etc.) affecting hemostasis preoperatively. 8)Patients with venous thromboembolic disease was observed within one year prior to surgery of this study or the patient with clinical signs or merger of deep vein thrombosis. 9)Ppatients with contraindications of iodinated contrast agent. 10)Patients who have indwelling central venous catheter. 11)Patients treated with progesterone and estrogen formulation within 4 weeks before administration. 12)Patients receiving radiation therapy or systemic cancer chemotherapy within two weeks before the administration. 13)Patients is determined inappropriate as a test target by principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of VTE.
- Secondary Outcome Measures
Name Time Method